Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Davelizomib is a proteasome inhibitor that exhibits antineoplastic activity [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | Davelizomib is a proteasome inhibitor that exhibits antineoplastic activity [1]. |
Molecular Weight | 481.25 |
Formula | C21H26BF2N3O7 |
CAS No. | 2409841-51-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Davelizomib 2409841-51-4 Proteases/Proteasome Ubiquitination Proteasome inhibitor inhibit